Join
Live feed
·
PRReleasevia Quantisnow
Sutro Biopharma Inc. logo

Sutro Biopharma to Provide Data Update on STRO-002 and Plans for Registrational Path Forward in Advanced Ovarian Cancer

ByQuantisnow·Wall Street's wire, on your screen.
STRO· Sutro Biopharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track STRO (Sutro Biopharma Inc.) and more on Quantisnow.